VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administere...
Leadership
David T. Domzalski
CEO, President & Director
Iain A. Stuart Ph.D.
Chief Scientific Officer
Mutya Harsch J.D.
General Counsel, Chief Legal Officer & Company Secretary
